Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on X:
“Excellent update by Pathobiology Graduate Program at Brown University PhD student Kimberly Meza at El-Deiry Lab meeting Legorreta Cancer Center on some of her ongoing thesis work where she is studying the impact of PIM1 on RCC, the TRAIL pathway, and novel translational therapeutic strategies.”
More posts featuring Wafik S. El-Deiry on OncoDaily.
